Studies

CellWell record HH-432493

Vitamin D levels and skeletal quality of life in adult Langerhans cell histiocytosis

Christos Gravvanis; Marina Kouveletsou; Maria Yavropoulou; Eleftherios Chatzellis; Athanasios Papatheodorou; Dimitrios Christoulas; Ioannis Athanasopoulos; Athanasios D Anastasilakis; Polyzois Makras

2026

In plain language

In 45 adults with Langerhans cell histiocytosis, raising vitamin D levels over 3 months was associated with lower parathyroid hormone and bone resorption markers and improvements in some quality-of-life domains, without a control group.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-432493

Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.